Patrick Auberger was born in 1957. He is a Research Director at the French National Institute of Health and Medical Research (INSERM). He obtained his Ph.D. degree in molecular and cellular pharmacology at the University of Nice, France in 1983. From 1983 to 1996, he focused his research interest on the regulation of signal transduction and protease activation, first at the INSERM Unit 145 and next at the INSERM Unit 210. From 1996 to 1999, he was the Head of the Hematopoietic Cell Activation Laboratory (INSERM CJF 9605 entitled Hematopoietic Cell Activation). Next, from 2000 to 2007, he was the Director of the Cell Death, Differentiation and Cancer Unit (INSERM U526) at the Medical Faculty of Nice. From 2008 to 2011, he served as the Scientific Deputy Director of the Centre Méditerranéen de Médecine Moleculaire (C3M/INSERM U895). In 2012, he became the Director of this Institute (C3M/INSERM U1065). C3M gathers 12 research teams in the fields of cancer, metabolic diseases and host-pathogen interactions. He is also the head of Team 2 entitled Cell Death, Differentiation, Inflammation, and Cancer. His current research interests concern the implication of various forms of cell death in the regulation of differentiation, inflammation and cancer, more specially in hematopoietic malignancies (chronic myelogenous leukemia, multiple myeloma and myelodysplastic syndromes). In this context, most of the developed projects concern the resistance to chemotherapy in hematopoietic malignancies and new therapeutic strategies to circumvent resistance. Auberger is currently a Member of several important French National Councils and Committees (INSERM Scientific Committee, Scientific Committee of the French Association for Cancer Research (ARC), Scientific Council of the National Institute of Canceropole (INCA), and Scientific Committee of the French National League against Cancer (LNCC).
Biography Updated on 21 June 2012